Report
Sharad Kumar S.P

Gimv ‘The time is now', Step into a solid private equity compounder

Gimv's €247.0m rights issue (€242.1m net proceeds) successfully closed. A 7.15m shares started trading on the Euronext Brussels. We believe Gimv's new strategy marks the beginning of a new growth phase. By FY30, Gimv aims to double its portfolio value to approximately €3.5bn. This will be achieved by doubling its average ticket size to €50.0m, increasing its target portfolio return to 17.5%, and utilizing available dry powder of around €645.0m (KBCSe). Additionally, Gimv will extend the holding period for ‘anchor' participations such as Cegeka. This allows Gimv to fully realize the growth potential of these companies. We think Gimv will succeed thanks to its consistent compounding, efficient capital allocation and expertise in bolt-on acquisitions. We updated our model for the rights issue and all transactions post 1H FY25 results and estimate NAVps and TEVps to be €52.4 and €55.8. We resume coverage with a BUY rating and €56.0 TP, a 0% discount to our est. TEVps.
Underlying
Gimv NV

GIMV is a listed investment company, specializing in private equity and venture capital and active in small and medium buyouts, growth financing and technology investments. Co. is also present with technology investments across Europe and in Israel, Japan and the USA. Co. invests in ICT (Technology), environmentally friendly technology (Cleantech) and Life Sciences.

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Sharad Kumar S.P

Other Reports on these Companies
Other Reports from KBC Securities
Michiel Declercq ... (+6)
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch